Rouleaux (stacked clumps) of red blood cells (RBCs) observed in the blood of COVID-19
patients in three studies call attention to the properties of several enveloped virus strains …

Experimental findings for SARS-CoV-2 related to the glycan biochemistry of coronaviruses
indicate that attachments from spike protein to glycoconjugates on the surfaces of red blood …

Consistent with well-established biochemical properties of coronaviruses, sialylated glycan
attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus's …

Glycans of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike
protein are speculated to play functional roles in the infection processes as they extensively …

The SARS-CoV-2 spike protein is heavily glycosylated, having 22 predicted N-glycosylation
sites per monomer. It is also O-glycosylated, although the number of O-glycosites is less …

The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a
global impact both in terms of human disease as well as socially and economically. Its …

ABSTRACT The SARS-CoV-2 coronavirus, the etiologic agent of COVID-19, uses its spike
(S) glycoprotein anchored in the viral membrane to enter host cells. The S glycoprotein is the …

Glycans on the host cell membrane and viral proteins play critical roles in pathogenesis.
Highly glycosylated epithelial cells represent the primary boundary separating embedded …

The current emergence of the novel coronavirus pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) demands the development of new …

The glycosylation of viral envelope proteins can play important roles in virus biology and
immune evasion. The spike (S) glycoprotein of severe acute respiratory syndrome …